Show Summary Details
Page of

Movement Disorders: Structural and Functional Imaging 

Movement Disorders: Structural and Functional Imaging
Movement Disorders: Structural and Functional Imaging

David J. Brooks

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 January 2021

In this chapter the value of structural and functional imaging for diagnosing, understanding, and managing movement disorders and their complications will be discussed. The relative roles of magnetic resonance imaging, transcranial sonography, positron emission tomography (PET), and single photon emission computed tomography (SPECT) will be contrasted. It is argued that imaging biomarkers play a valuable role in supporting diagnoses in parkinsonian disorders when these are unclear and in providing a rationale for the use of dopaminergic medications. Imaging can also detect subclinical disease activity in at-risk subjects and monitor the functional effects of putative neuroprotective and restorative therapies.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.